Item 7.01. Regulation FD Disclosure
On April 29, 2022, 180 Life Sciences Corp. (the "Company") issued a press
release announcing the publication of positive Phase 2b Dupuytren's Disease
study results.
A copy of the press release is furnished hereto as Exhibit 99.1, and
incorporated into this Item 7.01 by reference.
The information in Item 7.01 of this Form 8-K and Exhibit 99.1 attached hereto,
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a
filing. The furnishing of this Report is not intended to constitute a
determination by the Company that the information is material or that the
dissemination of the information is required by Regulation FD.
The press release furnished as Exhibit 99.1 to this Current Report on Form 8-K,
contains forward-looking statements within the safe harbor provisions under the
federal securities laws, including The Private Securities Litigation Reform Act
of 1995, and, as such, may involve known and unknown risks, uncertainties and
assumptions. These forward-looking statements relate to the Company's current
expectations and are subject to limitations and qualifications set forth in the
press release, as well as in the Company's other filings with the Securities and
Exchange Commission, including, without limitation, that actual events and/or
results may differ materially from those projected in such forward-looking
statements. These statements also involve known and unknown risks, which may
cause the results of the Company, its divisions and concepts to be materially
different than those expressed or implied in such statements. Accordingly,
readers should not place undue reliance on any forward-looking statements.
Forward-looking statements may include comments as to the Company's beliefs and
expectations as to future financial performance, events and trends affecting its
business and are necessarily subject to uncertainties, many of which are outside
the Company's control. More information on potential factors that could affect
the Company's financial results is included from time to time in the "Cautionary
Statement Regarding Forward-Looking Information," "Risk Factors" and
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" sections of the Company's periodic and current filings with the SEC,
including the Form 10-Qs and Form 10-Ks, filed with the SEC and available at
www.sec.gov. Forward-looking statements speak only as of the date they are made.
The Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise that occur after that date, except as otherwise provided by
law.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Description
99.1* Press Release dated April 29, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Furnished herewith.
1
© Edgar Online, source Glimpses